This distinction may be clinically meaningful, as the antiviral effector pathways suppressed by IL-13 in our study include genes previously linked to airflow obstruction and epithelial injury during viral infections (e.g., IFITM1/3)(39). Here, IFITM1 is linked to viral infectious disease.